ArticleJAMA network open2025

Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes.

Romain Neugebauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.